Zeus ELISA SARS-CoV-2 IgG Test System Receives Expanded Automation Claims Through FDA EUA
The assay utilizes a dual antigen combination of recombinant S1 receptor binding domain (RBD) viral protein and recombinant nucleoprotein that detects immune responses that other antibody tests may miss.
Read More